Monoclonal antibody 266
Alternative Names: Anti-Abeta Antibody m266 Fab; Anti-beta-amyloid monoclonal antibody 266; Biotinylated m266 antibody - Eli Lilly and Company; m266; m266 Fab; m266B antibody - Eli Lilly and CompanyLatest Information Update: 24 Jul 2006
Price :
$50 *
At a glance
- Originator Washington University School of Medicine
- Developer Eli Lilly and Company
- Class Monoclonal antibodies
- Mechanism of Action Amyloid beta-protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 24 Jul 2006 Data presented at the 10th International Conference on Alzheimer's Disease and Related Disorders (ICAD-2006) have been added to the pharmacokinetics and Alzheimer's Disease and Cognition Disorders pharmacodynamics sections
- 21 Jul 2006 Discontinued - Preclinical for Alzheimer's disease in USA (Injection)
- 21 Sep 2001 Preclinical development for Alzheimer's disease in USA (Unknown route)